<DOC>
	<DOCNO>NCT02973386</DOCNO>
	<brief_summary>This randomize , control , prospective phase III clinical trial . The purpose study evaluate acute toxicity efficacy concurrent cisplatin chemoradiation without capecitabine adjuvant chemotherapy Local Advanced Nasopharyngeal Carcinoma High Risk Distant Metastasis.Exploring Individualized comprehensive treatment plan reasonable , effective , low toxicity fit Modern radiotherapy technique Local Advanced Nasopharyngeal Carcinoma High Risk Distant Metastasis .</brief_summary>
	<brief_title>Prognostic Analysis Concurrent Chemoradiotherapy With/Without Adjuvant Chemotherapy Locally Advanced NPC Patients</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>Newly histologic diagnosis nasopharyngeal carcinoma ( WHO II/III ) Clinical stage III~IVb ( UICC/AJCC 7th ) Meet least one factor :1 primary tumor SUVmax &gt; 10 18FFDG PET/CT ; 2 T34N2M0 ; 5 T14N3M0 ; 6 EBVDNA PCR quantitative＞2×10E4 copy/l ( pretreatment ) . No distant metastasis Karnofsky Performance Status Scale≥70 WBC count ≥ 4×109/L，neutrophil differential count≥ 1.5×109/L , Hemoglobin ≥ 90g/L， platelet count ≥ 100×109/L ALT AST ≤2.5×ULN , bilirubin ≤2.5×ULN , Serum creatinine ≤1.5×ULN Serum creatinine clearance≥60ml/min Sign inform consent . Angle sexual squamous cell carcinoma basal cell layout , squamous cell carcinoma Younger 18 year old old 70 year old Are receive drug treanment kidney disease Have suffer tumor suffer tumor Have recieved chemotherapy radiotherapy Pregnancy lactation unstable heart disease need timely treatment Severe cerebrovascular disease/canker/psychosis/uncontrolled diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Local advance</keyword>
	<keyword>High Risk</keyword>
	<keyword>Nasopharyngeal Carcinoma</keyword>
</DOC>